<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0054">
 <label>54.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Covián</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fernández-Fierro</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Retamal-Díaz</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Díaz</surname>
    <given-names>FE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Vasquez</surname>
    <given-names>AE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lay</surname>
    <given-names>MK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Riedel</surname>
    <given-names>CA</given-names>
   </name>, 
   <name name-style="western">
    <surname>González</surname>
    <given-names>PA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bueno</surname>
    <given-names>SM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kalergis</surname>
    <given-names>AM</given-names>
   </name>, et al
  </person-group>
  <article-title>BCG-induced cross-protection and development of trained immunity: implication for vaccine design</article-title>. 
  <source>Front Immunol</source>. 
  <year>2019</year>;
  <volume>10</volume>:
  <fpage>2806</fpage>
  <comment>Published 2019 Nov 29</comment>. doi:
  <pub-id pub-id-type="doi">10.3389/fimmu.2019.02806</pub-id>.
  <pub-id pub-id-type="pmid">31849980</pub-id>
 </mixed-citation>
</ref>
